Explained herein are pharmaceutical packaging programs which prevent oxidative degradation of morphine, hydromorphone, promethazine and other oxygen-sensitive drugs, such units which include a syringe with an oxygen permeable suggestion cap, a hermetically sealed oxygen barrier blister packaging wit